Navigation Links
David Rose to present Howe School lecture on new technologies and business models, Jan. 29
Date:1/16/2009

HOBOKEN, N.J. - Internationally known technology expert David S. Rose will present a lecture at Stevens Institute of Technology, January 29, 2009, titled "Everything You Think You Know...Is Wrong: How New Technologies and Newer Business Models are Turning the World Upside Down."

As part of the Heath Lecture Series at the Wesley J. Howe School of Technology Management, Rose will discuss the latest technologies and concepts that are essential for doing business in the 21st century.

The lecture is free and open to the public. It will be held from 5 p.m. to 6:15 p.m., Thursday, January 29, in room 122 of the Lawrence T. Babbio, Jr. Center at Stevens Institute of Technology, corner of 6th and River Streets, Hoboken, N.J.

At a time when technological advances are fundamentally altering the way business and society function, understanding where things are going is more important than ever.

Rose, whom Businessweek heralded as a "world conquering entrepreneur," sees more than 500 business plans each year from entrepreneurs, leveraging the latest technology to change the way people think about business. His insights will benefit both Stevens' students and the general public.

Rose is a technology visionary and investor who has founded or funded more than 70 pioneering companies that are helping to define the future. He is well known in the technology community for discovering and mentoring high-potential entrepreneurs who are breaking new ground in technology-enabled businesses. He is a regular speaker at Yale, Harvard, Columbia and NYU business schools, and was a founding member of the New York New Media Association.

Rose is one of the country's most active early-stage technology investors. He is the founder and Chairman of New York Angels, one of the country's leading technology investment groups; Managing Principal of Rose Tech Ventures, specializing in highly scalable, Internet-based business; and Chairman of Egret Capital Partners, a
'/>"/>

Contact: Stephanie Mannino
smannino@stevens.edu
201-216-5602
Stevens Institute of Technology
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Protein folding researcher David Baker to receive Sackler Prize in Biophysics
2. David Salt is worth his salt, says Science magazine
3. Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh
4. American Society for Microbiology honors David J. Lipman
5. Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU
6. Prof. David Kisailus studies engineering and invention on the half-shell
7. David H. Ledbetter, PhD, FACMG is the 2008-2009 Luminex/ACMGF Award recipient
8. New manual presents robust, state-of-the-art proteomics methods for teaching and research
9. Hobbit fossils represent a new species, concludes University of Minnesota anthropologist
10. UAF researchers to present at AGU press briefing
11. New gene variants present opportunities in nutrigenomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...
(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...
(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...
Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2Tryptophan-enriched diet reduces pig aggression 2Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3
... A new method for manipulating macromolecules has been developed ... The technique uses double-stranded DNA to direct the behavior ... duplex DNA has been used as a static lattice ... manipulating DNA alone into such shapes, the researchers are ...
... Desert is the most lifeless spot on the face of the ... team of NASA scientists there earlier this month. , The University ... (MOA) they'd built could detect life in that crusty, arid land, ... life on the planet Mars. , In a place that hadn't ...
... China and the United States have found evidence of ... previous earliest evidence of lichen was 400 million years ... the scarce fossil record of fungi and raises new ... with the Nanjing Institute of Geology and Palaeontology; Shuhai ...
Other Biology News:DNA constraints control structure of attached macromolecules 2Life detection instrument passes key test on road to Mars 2Life detection instrument passes key test on road to Mars 3Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils 2Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils 3
(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...
(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...
(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...
(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...
Breaking Biology Technology:BioMS Medical Announces 2009 Year End Results 2BioMS Medical Announces 2009 Year End Results 3BioMS Medical Announces 2009 Year End Results 4BioMS Medical Announces 2009 Year End Results 5BioMS Medical Announces 2009 Year End Results 6BioMS Medical Announces 2009 Year End Results 7BioMS Medical Announces 2009 Year End Results 8BioMS Medical Announces 2009 Year End Results 9BioMS Medical Announces 2009 Year End Results 10PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 2PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 2Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 3Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 4Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher 5Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 2Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 3Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 4
... of a Promising New Flavor Ingredient Achieves ... Collaboration Milestone, ... SNMX ), a leading company focused on using proprietary,technologies to discover ... industries, announced today that it has,received a payment from The Coca-Cola ...
... Live On Company,s Website -, TUSTIN, Calif., Oct. ... clinical stage biopharmaceutical,company developing monoclonal antibodies for the treatment ... management will,present at the BIO Investor Forum 2008 on ... EDT). The conference will be held at the Palace ...
... Both 12-month pivotal studies in patients with symptomatic ... - Data show reductions in moderate and severe ... authorisation in EU and US expected in 2009, ... US to be initiated, ZURICH, Switzerland, Oct. ...
Other Biology Technology:SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 3
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Mouse monoclonal [002-49] to C1s ( Abpromise for all tested applications). entrezGeneID: 716 SwissProtID: P09871...
Goat polyclonal to HSPC150 ( Abpromise for all tested applications). entrezGeneID: 29089...
Biology Products: